English 日本語

#Orexin

List of IR information related to "Orexin".

1 IR Posts
1 Companies
11 days ago Last Updated

Filters

Reset
Period:
Importance:
1 IR Posts
4502 Takeda Pharmaceutical Company Limited
2026/02/10
Acceptance of New Drug Application for Oveporexton (TAK-861), a Potential First-in-Class Treatment for Narcolepsy Type 1, by the U.S. Food and Drug Administration and Designation for Priority Review

Takeda Pharmaceutical has announced that the FDA has accepted the new drug application for oveporexton, a treatment for narcolepsy type 1, and designated it for priority review. The target date for review completion is Q3 2026.

#TakedaPharmaceuticalCompany #NewDrugApplication #Narcolepsy
Scroll to Top